Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IHC.L
BUYInspiration Healthcare Group plc · Healthcare · United Kingdom · $27M · Avg Vol: $17K/d
COMPANY DESCRIPTION
Inspiration Healthcare Group plc designs, manufactures, and distributes specialized medical devices for neonatal intensive care, operating theatres, and home healthcare. The company's competitive moat is built on its proprietary, high-quality product portfolio and established relationships with healthcare providers globally. It operates as a global niche leader, benefiting from resilient demand and high regulatory barriers to entry in the neonatal care sector.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54.2M | 54.4M | 49.7M | 50.5M | 62.8M | 3.7% | 62.8M | 53.4M | 43.7M | -16.6% |
| EPS | 0.07 | 0.01 | -0.12 | -0.25 | 0.02 | -31.5% | -0.01 | — | — | — |
| Shares | 68.1M | 68.1M | 68.2M | 89.7M | 89.7M | +31.6% | 89.7M | — | — | — |
| Debt | 10.0M | 17.3M | 16.9M | 19.8M | 15.5M | 11.8% | 15.5M | — | — | — |
| Equity | 46.8M | 46.8M | 38.2M | 22.0M | 20.7M | -18.5% | — | — | — | — |
| Op CF | 4.7M | -4.6M | 2.7M | -2.0M | 10.0M | 20.5% | 10.0M | — | — | — |
| Inv CF | -5.2M | -11.0M | -3.5M | -2.3M | -3.9M | — | — | — | — | — |
| Fin CF | -1.3M | 6.3M | -1.6M | 4.8M | -5.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IHC.L are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IHC.L | Inspiration Healthcare Group plc(you) | $27M | 69 | BUY |
| EKF.L | EKF Diagnostics Holdings plc | $153M | 79 | BUY |
| CREO.L | Creo Medical Group PLC | $87M | 31 | SELL |
| NIOX.L | NIOX Group Plc | $319M | 87 | STRONG BUY |
| LIVN | LivaNova PLC | $4.3B | 80 | BUY |
| OHGR.L | One Health Group Plc | $45M | 73 | BUY |
| AREC.L | Arecor Therapeutics plc | $34M | 58 | HOLD |
| PXS.L | Provexis plc | $39M | 44 | HOLD |
| ABDX.L | Abingdon Health Plc | $34M | 41 | HOLD |
| SNN | Smith & Nephew plc | $12.9B | 81 | STRONG BUY |
Peer medians: ROE 0.2% · P/E 24.7x · Gross margin 56.9%